CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 20, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2027

Conditions

Advanced Solid Tumors

Interventions

DRUG

CVL237 tablets

CVL237 tablets, 200 mg, taken with food once daily for 28 consecutive days as a treatment cycle.

Trial Locations (1)

Li Ning, Beijing

All Listed Sponsors

lead

Convalife (Shanghai) Co., Ltd.

INDUSTRY

NCT06183736 - CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency | Biotech Hunter | Biotech Hunter